Literature DB >> 21194536

Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis.

Laura De Vargas Roditi1, Franziska Michor.   

Abstract

Cancer results from the accumulation of alterations in oncogenes and tumor suppressor genes. Tumor suppressors are classically defined as genes which contribute to tumorigenesis if their function is lost. Genetic or epigenetic alterations inactivating such genes may arise during somatic cell divisions or alternatively may be inherited from a parent. One notable exception to this rule is the BRCA1 tumor suppressor that predisposes to hereditary breast cancer when lost. Genetic alterations of this gene are hardly ever observed in sporadic breast cancer, while individuals harboring a germline mutation readily accumulate a second alteration inactivating the remaining allele--a finding which represents a conundrum in cancer genetics. In this paper, we present a novel mathematical framework of sporadic and hereditary breast tumorigenesis. We study the dynamics of genetic alterations driving breast tumorigenesis and explore those scenarios which can explain the absence of somatic BRCA1 alterations while replicating all other disease statistics. Our results support the existence of a heterozygous phenotype of BRCA1 and suggest that the loss of one BRCA1 allele may suppress the fitness advantage caused by the inactivation of other tumor suppressor genes. This paper contributes to the mathematical investigation of breast tumorigenesis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194536      PMCID: PMC3713469          DOI: 10.1016/j.jtbi.2010.12.033

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  30 in total

1.  The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients.

Authors:  Stephen J Elledge; Angelika Amon
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

2.  In search of the tumour-suppressor functions of BRCA1 and BRCA2.

Authors:  R Scully; D M Livingston
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 3.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Authors:  P L Welcsh; M C King
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

Review 4.  Understanding mathematical models for breast cancer risk assessment and counseling.

Authors:  D M Euhus
Journal:  Breast J       Date:  2001 Jul-Aug       Impact factor: 2.431

5.  Acceleration of chromosomal instability of BRCA1-associated hereditary breast cancers by p53 abnormality.

Authors:  Yasuo Miyoshi; Kyoko Iwao; Noriko Ikeda; Chiyomi Egawa; Shinzaburo Noguchi
Journal:  Breast J       Date:  2002 Mar-Apr       Impact factor: 2.431

6.  Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability.

Authors:  Natalia L Komarova; Anirvan Sengupta; Martin A Nowak
Journal:  J Theor Biol       Date:  2003-08-21       Impact factor: 2.691

7.  Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

Authors:  Lao H Saal; Sofia K Gruvberger-Saal; Camilla Persson; Kristina Lövgren; Mervi Jumppanen; Johan Staaf; Göran Jönsson; Maira M Pires; Matthew Maurer; Karolina Holm; Susan Koujak; Shivakumar Subramaniyam; Johan Vallon-Christersson; Håkan Olsson; Tao Su; Lorenzo Memeo; Thomas Ludwig; Stephen P Ethier; Morten Krogh; Matthias Szabolcs; Vundavalli V V S Murty; Jorma Isola; Hanina Hibshoosh; Ramon Parsons; Ake Borg
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

Review 8.  BRCA1 gene in breast cancer.

Authors:  Eliot M Rosen; Saijun Fan; Richard G Pestell; Itzhak D Goldberg
Journal:  J Cell Physiol       Date:  2003-07       Impact factor: 6.384

9.  BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.

Authors:  Anne-Renee Hartman; James M Ford
Journal:  Nat Genet       Date:  2002-08-26       Impact factor: 38.330

Review 10.  The p53 pathway in breast cancer.

Authors:  Milena Gasco; Shukri Shami; Tim Crook
Journal:  Breast Cancer Res       Date:  2002-02-12       Impact factor: 6.466

View more
  5 in total

1.  Evolutionary pathways in BRCA1-associated breast tumors.

Authors:  Filipe C Martins; Subhajyoti De; Vanessa Almendro; Mithat Gönen; So Yeon Park; Joanne L Blum; William Herlihy; Gabrielle Ethington; Stuart J Schnitt; Nadine Tung; Judy E Garber; Katharina Fetten; Franziska Michor; Kornelia Polyak
Journal:  Cancer Discov       Date:  2012-04-10       Impact factor: 39.397

2.  BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression.

Authors:  Amanjit Bal; Sangeeta Verma; Kusum Joshi; Anuj Singla; Ravi Thakur; Sunil Arora; Gurpreet Singh
Journal:  Virchows Arch       Date:  2012-07-21       Impact factor: 4.064

Review 3.  Mathematical models of breast and ovarian cancers.

Authors:  Dana-Adriana Botesteanu; Stanley Lipkowitz; Jung-Min Lee; Doron Levy
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-06-03

4.  Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer.

Authors:  Qiuyun Li; Wei Wei; Y I Jiang; Huawei Yang; Jianlun Liu
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

5.  Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers.

Authors:  Kimiyo N Yamamoto; Kouji Hirota; Shunichi Takeda; Hiroshi Haeno
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.